[{"indications": "Indications\u00a0treatment of angina in patients in\r\nnormal sinus rhythm (see notes above)", "name": "IVABRADINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.6 Nitrates, calcium-channel blockers, and other antianginal drugs", "2.6.3 Other antianginal drugs"], "cautions": "Cautions\u00a0mild heart failure including asymptomatic left ventricular dysfunction; monitor\r\nfor atrial fibrillation or other arrhythmias (treatment\r\nineffective); hypotension (avoid if severe); retinitis pigmentosa; elderly; interactions: Appendix 1 (ivabradine)", "side-effects": "Side-effects\u00a0bradycardia, first-degree heart block, ventricular\r\nextrasystoles; headache, dizziness; visual disturbances including\r\nphosphenes and blurred vision; less commonly nausea,\r\nconstipation, diarrhoea, palpitations, supraventricular extrasystoles,\r\ndyspnoea, vertigo, muscle cramps, eosinophilia, hyperuricaemia, and\r\nraised plasma-creatinine concentration", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/129514.htm", "doses": ["Initially 5\u00a0mg  twice daily, increased if necessary after\r\n3\u20134 weeks to 7.5\u00a0mg twice daily (if not tolerated reduce dose to 2.5\u20135\u00a0mg\r\ntwice daily); elderly initially 2.5\u00a0mg\r\ntwice daily", "Ventricular rate at rest should not be allowed\r\nto fall below 50 beats per minute"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid\u2014toxicity in animal studies"}]